Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RR-HNK in Adults With Obsessive-Compulsive Disorder
NCT06575075Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of (2R,6R)-hydroxynorketamine in obsessive compulsive disorder (OCD). Started Jan 2026; status: recruiting.
02
Drugs
(2R,6R)-hydroxynorketamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT06575075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06575075.